CFO Robert Schrader sold $299K of PAYX shares at $115.09, reducing his direct holdings by 12.3% while the stock traded just 2.2% below its 90-day high. This sale aligns with his historical pattern of 14 prior sells and no buys, though the absence of other insider selling clusters makes it less concerning than larger divestments.

Where it could go — Our 5-6 conviction officer sells: 51% beat SPY at 30d (n=1456, avg +3.4% vs SPY); watch $117.72 as resistance, $93.02 as support.

VP Christopher Simmons sold $303K of PAYX shares at $115.92, reducing his direct stake by 43% near the stock's 90-day high. This annual pattern of selling lacks cluster support and aligns with analyst caution, suggesting routine diversification rather than urgent concern.

Where it could go — Our 1-4 conviction officer sells: 58% beat SPY at 30d; watch $117.72 as resistance, $93.02 as support.

Director Mucci Martin sold $2.7M of PAYX shares, reducing their direct holdings by 5.3% at $109.93, just 1.5% below the 90-day high. This appears to be part of their routine annual selling pattern with no supporting buyers, aligning with analyst HOLD consensus.

Where it could go — Our 1-4 conviction sells: 55% beat SPY at 30d with avg +1.4% vs SPY.

Director Joseph Tucci sold $384K worth of PAYX shares at $98.25, reducing his directly held stake by 5.5% while the stock traded 4.9% below its 90-day high. This continues Tucci's established selling pattern with no offsetting insider buying activity, though the transaction size is relatively small compared to his historical sales.

Where it could go — Analyst mean target unavailable; bear case if stock breaks below recent support levels.